Holen Sie sich die Stockscreener-App
40.40
1.61%
-0.66
Schlusskurs vom Vortag:
$41.06
Offen:
$41.44
24-Stunden-Volumen:
546
Relative Volume:
0.05
Marktkapitalisierung:
$162.66M
Einnahmen:
$17,000
Nettoeinkommen (Verlust:
$-23.87M
KGV:
-12.95
EPS:
-3.12
Netto-Cashflow:
$-22.03M
1W Leistung:
+2.02%
1M Leistung:
+25.23%
6M Leistung:
+145.44%
1J Leistung:
+188.37%
1-Tages-Spanne:
$41.30
$41.44
1-Wochen-Bereich:
$39.98
$44.00
52-Wochen-Spanne:
$13.20
$44.00
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Firmenname
Vtv Therapeutics Inc
Sektor
Branche
Telefon
336-841-0300
Adresse
3980 PREMIER DR, HIGH POINT, NC
Vergleichen Sie VTVT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
41.30 | 161.70M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.36 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
811.17 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.74 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.36 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.32 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Eingeleitet | TD Cowen | Buy |
| 2025-11-19 | Eingeleitet | BTIG Research | Buy |
| 2019-05-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-04-10 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-08 | Eingeleitet | Northland Capital | Outperform |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-09-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-24 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-08-24 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vtv Therapeutics Inc Aktie (VTVT) Neueste Nachrichten
Smart Money: Can vTv Therapeutics Inc. (5VT0) stock attract analyst upgrades2025 Growth vs Value & Target Return Focused Stock Picks - ulpravda.ru
How vTv Therapeutics Inc. (5VT0) stock reacts to new regulationsRate Hike & Free Accurate Trade Setup Notifications - ulpravda.ru
Why institutional investors increase stakes in vTv Therapeutics Inc. (5VT0) stockWeekly Risk Summary & Daily Technical Stock Forecast Reports - ulpravda.ru
P 500 performance this yearJuly 2025 Levels & Real-Time Market Trend Scan - ulpravda.ru
Momentum Shift: How vTv Therapeutics Inc. (5VT0) stock reacts to new regulations2025 AllTime Highs & Daily Stock Trend Reports - ulpravda.ru
Should I hold or sell vTv Therapeutics Inc. stock in 2025July 2025 Final Week & Growth Focused Stock Pick Reports - ulpravda.ru
Brokerages Set vTv Therapeutics Inc. (NASDAQ:VTVT) PT at $51.33 - Defense World
Is vTv Therapeutics Inc. stock supported by innovation pipeline2026 world cup usa national team group stage goalkeepers build up play knockout prediction statistical analysis - ulpravda.ru
TD Cowen Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
An Alzheimer’s Drug Could Supercharge This High-Risk Stock. Is It Worth a Buy Here? - Yahoo Finance
vTv Therapeutics Inc. (NASDAQ:VTVT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
VTVT: TD Cowen Initiates Coverage with a Buy Rating and $67 Pric - GuruFocus
vTv Therapeutics (NASDAQ:VTVT) Now Covered by Analysts at TD Cowen - MarketBeat
This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
vTv Therapeutics stock initiated with Buy rating at TD Cowen By Investing.com - Investing.com Canada
How Vtv Therapeutics Inc. (VTVT) Affects Rotational Strategy Timing - Stock Traders Daily
Will vTv Therapeutics Inc. (5VT0) stock test record highs in 2025Bullish Engulfing Patterns & Outstanding Growth Opportunities - bollywoodhelpline.com
vTv Therapeutics (NASDAQ:VTVT) Upgraded at Wall Street Zen - MarketBeat
Discipline and Rules-Based Execution in VTVT Response - Stock Traders Daily
vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
vTv Therapeutics stock price target raised to $47 from $36 at H.C. Wainwright - Investing.com Canada
How vTv Therapeutics Inc. stock reacts to global recession fearsJuly 2025 Highlights & Weekly Stock Breakout Alerts - Улправда
Can vTv Therapeutics Inc. stock double in next 5 yearsJuly 2025 Levels & Real-Time Market Trend Scan - Улправда
Will vTv Therapeutics Inc. (5VT0) stock announce special dividend2025 Pullback Review & Free Technical Pattern Based Buy Signals - Улправда
How vTv Therapeutics Inc. stock performs in interest rate cyclesWeekly Market Report & Consistent Income Trade Ideas - Улправда
What technical charts say about vTv Therapeutics Inc. stock2025 Price Action Summary & Low Drawdown Momentum Ideas - Улправда
EV Market: How vTv Therapeutics Inc. stock valuations compare to rivals2025 Technical Overview & Consistent Income Trade Recommendations - moha.gov.vn
HC Wainwright & Co. Raises Price Target for VTVT to $47 | VTVT S - GuruFocus
HC Wainwright & Co. Maintains vTv Therapeutics (VTVT) Buy Recommendation - Nasdaq
Is vTv Therapeutics Inc. stock recession proof2025 AllTime Highs & Low Risk High Win Rate Picks - DonanımHaber
We're Interested To See How vTv Therapeutics (NASDAQ:VTVT) Uses Its Cash Hoard To Grow - Yahoo Finance
Why vTv Therapeutics Inc. (5VT0) stock appeals to dividend investorsJuly 2025 Update & Fast Momentum Stock Entry Tips - DonanımHaber
Aug Sentiment: What hedge fund activity signals for vTv Therapeutics Inc stock2025 Support & Resistance & Technical Pattern Based Signals - moha.gov.vn
Rally Mode: How vTv Therapeutics Inc. stock reacts to global recession fearsTrade Exit Report & Weekly Breakout Stock Alerts - Улправда
vTv Therapeutics submits protocol for phase 2 diabetes drug trial By Investing.com - Investing.com South Africa
VTVT FinancialsIncome Statement - Quiver Quantitative
vTv Therapeutics submits protocol for phase 2 diabetes drug trial - Investing.com India
vTv Therapeutics Announces Phase 2 Clinical Study for Cadisegliatin in Type 2 Diabetes in Collaboration with M42’s IROS - Quiver Quantitative
vTv Therapeutics and M42’s IROS Announce Submission of - GlobeNewswire
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health - Sahm
Will vTv Therapeutics Inc. (5VT0) stock hit Wall Street targets2025 Trading Volume Trends & Reliable Price Breakout Signals - Улправда
vTv Therapeutics Earnings Notes - Trefis
Investment Report: Is vTv Therapeutics Inc stock oversold or undervaluedJuly 2025 Short Interest & Low Drawdown Trading Techniques - moha.gov.vn
(VTVT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
vTv Therapeutics’ Promising Phase 3 Study on Cadisegliatin for Type 1 Diabetes - MSN
Alzheimer’s Disease Market in the 7MM is USD 5,048 million in 2025, analyses DelveInsight - The Globe and Mail
Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect? - MSN
Big Money Moves: Why vTv Therapeutics Inc stock remains a top recommendation - moha.gov.vn
vTv Therapeutics (NASDAQ:VTVT) Stock Crosses Above Fifty Day Moving AverageHere's What Happened - MarketBeat
Why vTv Therapeutics Inc. stock remains a top recommendationM&A Rumor & High Accuracy Swing Trade Signals - Newser
What makes vTv Therapeutics Inc. (5VT0) stock appealing to growth investorsWeekly Profit Summary & Consistent Income Trade Ideas - Newser
Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):